» Articles » PMID: 28965701

Environmental Exposure to Manganese in Air: Tremor, Motor and Cognitive Symptom Profiles

Overview
Journal Neurotoxicology
Date 2017 Oct 3
PMID 28965701
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Excessive exposure to manganese (Mn) may cause parkinsonian-like motor and tremor symptoms and adverse cognitive effects, including problems with executive functioning (EF), resembling those found in later-stage Parkinson's disease (PD). Studies seeking to differentiate PD patients into subgroups with associated cognitive and functional outcomes using motor and tremor symptoms identified tremor-dominant (TD) and non-tremor dominant (NTD) subtypes. It is unclear whether differing patterns of pathophysiology and symptoms exist in Mn neurotoxicity, as they do in PD.

Methods: Residents of East Liverpool (n=83) and Marietta, OH (n=99) exposed to chronic (>10years) environmental Mn through industrial pollution were administered neuropsychological measures and a physician-rated scale of movement-disorder symptoms. Two-step cluster analysis was used to group residents based on tremor symptoms, bradykinesia/rigidity symptoms, gait disturbance, and executive function. Cluster membership was validated using modeled air-Mn exposure and a computerized tremor measure.

Results: Elevated tremor and motor symptoms and executive dysfunction were observed, and TD and NTD symptom clusters were identified. Two additional clusters were also identified: Executive Dysfunction and Normal Functioning. The NTD residents, with elevated levels of gait disturbance and other movement disorder symptoms, did not evidence EF impairment, as predicted. Instead, residents with EF impairment formed their own cluster, and were relatively free of movement disorder symptoms.

Conclusions: Results resemble reports in the PD literature with TD and NTD clusters identified, but executive dysfunction did not cluster with NTD symptoms. PD and Mn exposure likely have differing pathophysiology and developmental courses, and therefore different symptom patterns, even when similar symptoms are present.

Citing Articles

Mitochondrially Transcribed dsRNA Mediates Manganese-induced Neuroinflammation.

Gokhale A, Mendez-Vazquez H, Sampson M, Moctezuma F, Harbuzariu A, Sing A bioRxiv. 2025; .

PMID: 40027638 PMC: 11870567. DOI: 10.1101/2025.02.16.638529.


Tremors in cats with hepatic encephalopathy-congenital portosystemic shunts or postattenuation neurological syndrome.

Liatis T, Bhatti S, Glanemann B, De Decker S Vet Rec. 2024; :e4746.

PMID: 39539156 PMC: 11698092. DOI: 10.1002/vetr.4746.


Sex-specific associations of a ferroalloy metal mixture with motor function in Italian adolescents.

Friedman A, Schildroth S, Fruh V, Krengel M, Tripodis Y, Placidi D Environ Epidemiol. 2024; 8(4):e321.

PMID: 39022189 PMC: 11254121. DOI: 10.1097/EE9.0000000000000321.


CYP1B1 affects the integrity of the blood-brain barrier and oxidative stress in the striatum: An investigation of manganese-induced neurotoxicity.

Wu J, Li Y, Tian S, Na S, Wei H, Wu Y CNS Neurosci Ther. 2024; 30(3):e14633.

PMID: 38429921 PMC: 10907825. DOI: 10.1111/cns.14633.


Divalent metal content in diet affects severity of manganese toxicity in Drosophila.

Ghosn Z, Sparks K, Spaulding J, Vutukuri S, Ahmed M, VanBerkum M Biol Open. 2023; 13(1).

PMID: 38117005 PMC: 10810561. DOI: 10.1242/bio.060204.


References
1.
Bowler R, Harris M, Gocheva V, Wilson K, Kim Y, Davis S . Anxiety affecting parkinsonian outcome and motor efficiency in adults of an Ohio community with environmental airborne manganese exposure. Int J Hyg Environ Health. 2011; 215(3):393-405. DOI: 10.1016/j.ijheh.2011.10.005. View

2.
Mergler D, Baldwin M, Belanger S, Larribe F, Beuter A, Bowler R . Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology. 1999; 20(2-3):327-42. View

3.
Guilarte T . Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates. Front Aging Neurosci. 2013; 5:23. PMC: 3690350. DOI: 10.3389/fnagi.2013.00023. View

4.
Guilarte T . Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect. 2010; 118(8):1071-80. PMC: 2920085. DOI: 10.1289/ehp.0901748. View

5.
Koller W, Lyons K, Truly W . Effect of levodopa treatment for parkinsonism in welders: A double-blind study. Neurology. 2004; 62(5):730-3. DOI: 10.1212/01.wnl.0000113726.34734.15. View